NEW YORK (GenomeWeb) – Invitae reported after the close of the market Monday that its first quarter revenues climbed 158 percent year over year, falling short of the consensus Wall Street estimate on the top line but beating the estimate on the bottom line.

The San Francisco-based genetic testing firm posted revenues of $10.3 million for the three-month period ended March 31, 2017, compared with $4 million for the first quarter of 2016. Despite the strong growth, the firm still fell shy of analysts' consensus estimate of $10.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.